AU2003267513A1 - Chromosome 3, 5 and 11 genes involved in premature canities - Google Patents

Chromosome 3, 5 and 11 genes involved in premature canities

Info

Publication number
AU2003267513A1
AU2003267513A1 AU2003267513A AU2003267513A AU2003267513A1 AU 2003267513 A1 AU2003267513 A1 AU 2003267513A1 AU 2003267513 A AU2003267513 A AU 2003267513A AU 2003267513 A AU2003267513 A AU 2003267513A AU 2003267513 A1 AU2003267513 A1 AU 2003267513A1
Authority
AU
Australia
Prior art keywords
chromosome
genes involved
premature canities
canities
premature
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003267513A
Other languages
English (en)
Other versions
AU2003267513A8 (en
Inventor
Stylianos Antonarakis
Jean-Louis Blouin
Olivier De Lacharriere
Claire Deloche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Publication of AU2003267513A8 publication Critical patent/AU2003267513A8/xx
Publication of AU2003267513A1 publication Critical patent/AU2003267513A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/06—Preparations for styling the hair, e.g. by temporary shaping or colouring
    • A61Q5/065—Preparations for temporary colouring the hair, e.g. direct dyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/148—Screening for cosmetic compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003267513A 2002-07-10 2003-07-09 Chromosome 3, 5 and 11 genes involved in premature canities Abandoned AU2003267513A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/08697 2002-07-10
FR0208697A FR2842105B1 (fr) 2002-07-10 2002-07-10 Localisation des genes impliques dans la canitie precoce
PCT/FR2003/002153 WO2004007764A2 (fr) 2002-07-10 2003-07-09 Genes des chromosomes 3,5 et 11 impliques dans la canitie precoce

Publications (2)

Publication Number Publication Date
AU2003267513A8 AU2003267513A8 (en) 2004-02-02
AU2003267513A1 true AU2003267513A1 (en) 2004-02-02

Family

ID=29763718

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003267513A Abandoned AU2003267513A1 (en) 2002-07-10 2003-07-09 Chromosome 3, 5 and 11 genes involved in premature canities

Country Status (7)

Country Link
EP (1) EP1520042A2 (fr)
JP (1) JP2005532407A (fr)
AU (1) AU2003267513A1 (fr)
BR (1) BR0305436A (fr)
CA (1) CA2491235A1 (fr)
FR (1) FR2842105B1 (fr)
WO (1) WO2004007764A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2864899A1 (fr) * 2004-01-08 2005-07-15 Oreal Differents genes impliques dans la canitie precoce
WO2005068650A2 (fr) * 2004-01-08 2005-07-28 L'oreal Divers genes impliques dans des canities precoces
RU2437212C2 (ru) 2006-11-06 2011-12-20 Квэлкомм Инкорпорейтед Способы и устройство для распределения мощности и/или выбора скорости передачи для операций mimo/simo восходящей линии с учетом par
FR2930775B1 (fr) 2008-04-30 2010-05-21 Oreal Utilisations de bnipxl-beta dans la canitie precoce
JP5695384B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子
JP5695383B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子
JP5695385B2 (ja) 2009-10-05 2015-04-01 花王株式会社 毛髪形状感受性遺伝子

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470577A (en) * 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US5858661A (en) * 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
WO2000047770A1 (fr) * 1999-02-15 2000-08-17 Catalyst Biomedica Ltd. Locus de susceptibilite de l'osteoarthrite

Also Published As

Publication number Publication date
BR0305436A (pt) 2004-09-28
AU2003267513A8 (en) 2004-02-02
FR2842105A1 (fr) 2004-01-16
FR2842105B1 (fr) 2012-12-28
WO2004007764A3 (fr) 2004-04-08
CA2491235A1 (fr) 2004-01-22
EP1520042A2 (fr) 2005-04-06
JP2005532407A (ja) 2005-10-27
WO2004007764A2 (fr) 2004-01-22

Similar Documents

Publication Publication Date Title
AU2003272187A1 (en) Novel nanoparticles and use thereof
AU2003202996A1 (en) Hair setting compositions, polymers and methods
AU2003266321A1 (en) Tetrahydropyrimidine-2-one derivatives and their uses
AU2002336367A1 (en) Adamts13 genes and proteins and variants, and uses thereof
ZA200406362B (en) N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials.
EP1617807A4 (fr) 1,4-diazepines substituees et leurs utilisations
AU2002329759A1 (en) Methyltransferase genes and uses thereof
AU2002364051A1 (en) Anti-cancer combination and use thereof
EP1392106A4 (fr) Genes tyra et utilisations associees
AU2002247269A1 (en) Genes and polymorphisms associated with cardiovascular disease and their use
IL161472A0 (en) In vitro micro-organs, and uses related thereto
AU2003290573A1 (en) Cross-linked oligomeric compounds and their use in gene modulation
AU2003252057A1 (en) Oligomeric dyes and use thereof
AU2003217421A1 (en) Prostate specific genes and the use thereof in design or therapeutics
AU2003267513A1 (en) Chromosome 3, 5 and 11 genes involved in premature canities
IL153573A0 (en) Clk-2, cek-7 and coq-4 genes, and uses thereof
AU2003231827A1 (en) Pseudo-tissues and uses thereof
AUPS198302A0 (en) Improvements in bowsprits
AU2003299491A1 (en) Fagopyritol synthase genes and uses thereof
AU2002350599A1 (en) Homeotic genes and proteins, and uses thereof
AU2003291426A1 (en) Gp64-pseudotyped vectors and uses thereof
AU2002332244A1 (en) Demelanizing agents, beautifying agents, demelanizing compositions and beautifying compositions
AU2003229906A1 (en) Stretptococcal genes involved in osmotic and oxidative stress and in virulence
GB0101300D0 (en) Primordial germ cell genes
GB0105922D0 (en) Genes and proteins, and their use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase